Event Details

On December 7th, Cognition hosted a virtual R&D symposium to discuss dementia with Lewy bodies (DLB) and the potential for treatment with a small molecule sigma-2 (σ-2) modulator. Company management will be joined at this digital event by representatives of the Lewy Body Dementia Association (LBDA) as well as James E. Galvin, M.D., a professor of neurology and the director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine.